|
KMID : 0811720120160050349
|
|
Korean Journal of Physiology & Pharmacology
2012 Volume.16 No. 5 p.349 ~ p.353
|
|
|
CTLA-4-Tg/CD-28-KO Mice Exhibit Reduced T Cell Proliferation in vivo Compared to CD-28-KO Mice in a Graft-versus-host Disease Model
|
|
Yoo Jong-Sun
Lee Yun-Jung
Yoon Joo-Won
Hyung Kyeong-Eun
Hwang Kwang-Woo
|
|
|
Abstract
|
|
|
|
Activated T cells express inhibitory receptors such as CTLA-4 that can downregulate immune responses. Blockade of or genetic deficiency in CTLA-4 can result in autoimmunity. Therefore, strategies to increase the inhibitory function of CTLA-4 may be attractive in settings of undesirable T cell responses such as autoimmunity or transplant rejection. We have tested the hypothesis that transgenic constitutive expression of CTLA-4 can further attenuate immune responses when compared with normal inducible expression. Our results indicate that transgenic expression of CTLA-4 in mouse T cells (CTLA-4-Tg T cells) results in reduced cell cycle progression and increased apoptosis of TCR-stimulated T cells. CTLA-4-Tg T cells display reduced T cell proliferation in an in vivo model of graft versus host disease (GVHD). These results further our understanding of how CTLA-4 can be manipulated to inhibit immune responses and may help development of new therapeutic strategies for clinical settings of autoimmunity and transplantation.
|
|
|
KEYWORD
|
|
|
Cell surface molecules, Cellular activation, T lymphocytes, Transgenic, Rodent
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|